Eargo Inc. (EAR)
2.57
-0.11 (-4.10%)
At close: Feb 15, 2024, 9:00 PM
Company Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States.
The company markets and sells hearing aids.
It sells its products direct-to-consumer and through omni-channel.
The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014.
Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
Eargo Inc.

Country | United States |
IPO Date | Oct 16, 2020 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 243 |
CEO | William H. Brownie |
Contact Details
Address: 2665 North First Street San Jose, California United States | |
Website | https://eargo.com |
Stock Details
Ticker Symbol | EAR |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001719395 |
CUSIP Number | 270087109 |
ISIN Number | US2700872086 |
Employer ID | 27-3879804 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
William H. Brownie | Interim Chief Executive Officer & Chief Operating Officer |
Christy La Pierre | Chief Legal Officer & Secretary |
Mark Thorpe | Chief Financial Officer |
Tim Trine Ph.D. | Chief Technology Officer |
Daniel Shen | Co-Founder and Chief Clinical & Science Officer |
Tricia Burchell | Senior Vice President of People Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 26, 2024 | 15-12G | Filing |
Feb 21, 2024 | S-8 POS | Filing |
Feb 21, 2024 | S-8 POS | Filing |
Feb 21, 2024 | S-8 POS | Filing |
Feb 20, 2024 | 4 | Filing |
Feb 20, 2024 | 4 | Filing |
Feb 20, 2024 | 4 | Filing |
Feb 20, 2024 | 4 | Filing |
Feb 20, 2024 | 4 | Filing |
Feb 20, 2024 | 4 | Filing |